Rallybio CorpRLYBEarnings & Financial Report
Nasdaq
RLYB Q3 2025 Key Financial Metrics
Revenue
$212.0K
Gross Profit
N/A
Operating Profit
$-6.9M
Net Profit
$16.0M
Gross Margin
N/A
Operating Margin
-3266.5%
Net Margin
7554.7%
YoY Growth
-29.1%
EPS
$0.36
Financial Flow
Rallybio Corp Q3 2025 Financial Summary
Rallybio Corp reported revenue of $212.0K for Q3 2025, with a net profit of $16.0M (7554.7% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $212.0K |
|---|---|
| Net Profit | $16.0M |
| Gross Margin | N/A |
| Operating Margin | -3266.5% |
| Report Period | Q3 2025 |
Rallybio Corp Annual Revenue by Year
Rallybio Corp annual revenue history includes year-by-year totals (for example, 2024 revenue was $600.0K).
| Year | Annual Revenue |
|---|---|
| 2024 | $600.0K |
Income Statement
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $299000 | $299000 | $2000 | $212000 | $212000 | $212000 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | -29.1% | -29.1% |
Balance Sheet
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $133.2M | $99.4M | $92.4M | $79.0M | $68.1M | $58.0M | $51.0M | $67.7M |
| Liabilities | $9.6M | $10.2M | $12.4M | $8.2M | $6.5M | $3.9M | $5.0M | $4.6M |
| Equity | $123.6M | $89.2M | $80.0M | $70.8M | $61.7M | $54.1M | $46.0M | $63.0M |
Cash Flow
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-16.5M | $-15.5M | $-10.4M | $-13.5M | $-9.9M | $-10.2M | $-8.4M | $-6.5M |